Crossmark

A biomimetic receptor for glucose

Crossref DOI link: https://doi.org/10.1038/s41557-018-0155-z

Published Online: 2018-11-12

Published Print: 2019-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tromans, Robert A.

Carter, Tom S. http://orcid.org/0000-0001-6488-1028
Chabanne, Laurent

Crump, Matthew P. http://orcid.org/0000-0002-7868-5818
Li, Hongyu http://orcid.org/0000-0001-5405-9401
Matlock, Johnathan V.

Orchard, Michael G. http://orcid.org/0000-0002-0651-2571
Davis, Anthony P. http://orcid.org/0000-0001-5213-624X
License Information

Text and Data Mining valid from 2018-11-12
More Information

Article History

Received: 31 December 2017

Accepted: 5 September 2018

First Online: 12 November 2018

Competing interests

: While this paper was under consideration, Ziylo Ltd was purchased by Novo Nordisk with a view to the development of glucose-responsive insulin. A new company Carbometrics was created to collaborate with Ziylo and explore other applications. A.P.D. was a director and shareholder of Ziylo, and is now a director and shareholder of Carbometrics. T.S.C., L.C., J.V.M. and M.G.O. were employees of Ziylo, J.V.M. and M.G.O. are now employees of Carbometrics.